KPIs & Operating Metrics(New)
Growth Metrics

Amgen (AMGN) Acquisitions (2017 - 2022)

Amgen has reported Acquisitions over the past 10 years, most recently at $3.8 billion for Q4 2022.

  • For Q4 2022, Acquisitions rose 331.35% year-over-year to $3.8 billion; the TTM value through Dec 2022 reached $4.7 billion, up 425.14%, while the annual FY2025 figure was $53.0 million, N/A changed from the prior year.
  • Acquisitions for Q4 2022 was $3.8 billion at Amgen, up from $890.0 million in the prior quarter.
  • Over five years, Acquisitions peaked at $13.4 billion in Q4 2019 and troughed at -$197.0 million in Q1 2018.
  • A 4-year average of $2.6 billion and a median of $177.0 million in 2019 define the central range for Acquisitions.
  • Biggest five-year swings in Acquisitions: crashed 89.47% in 2018 and later surged 671900.0% in 2019.
  • Year by year, Acquisitions stood at $2.0 million in 2018, then surged by 671900.0% to $13.4 billion in 2019, then tumbled by 93.38% to $890.0 million in 2021, then skyrocketed by 331.35% to $3.8 billion in 2022.
  • Business Quant data shows Acquisitions for AMGN at $3.8 billion in Q4 2022, $890.0 million in Q4 2021, and $13.0 million in Q3 2021.